| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.3M | -34.1% |
| SG&A Expense | $5.6M | +17.7% |
| Operating Income | -$14.9M | +21.0% |
| Income Tax | $0 | — |
| Net Income | -$14.9M | +21.2% |
| EPS (Basic) | -$38.87 | -677.4% |
| EPS (Diluted) | -$38.87 | -677.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | +1077.5% |
| Current Assets | $8.7M | +444.2% |
| Total Assets | $8.7M | +411.6% |
| Current Liabilities | $2.5M | -58.8% |
| Total Liabilities | $2.5M | -58.8% |
| Stockholders' Equity | $6.2M | +239.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.1M | -21.0% |
| Capital Expenditures | $4K | +7.4% |
| Investing Cash Flow | -$4K | -7.4% |
| Financing Cash Flow | $23.0M | +396.6% |
| Free Cash Flow | -$17.1M | -21.0% |